Daily dornase alfa after aneurysm bleed for better recovery
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether giving dornase alfa daily for up to 14 days after a subarachnoid hemorrhage (a type of bleeding around the brain from a burst aneurysm) helps people be more independent 6 months later. It is for people whose bleeding started less than 48 hours ago and whose aneurysm has already been treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a subarachnoid hemorrhage (bleeding around the brain) from a burst aneurysm.
- Your symptoms started less than 48 hours ago.
- The aneurysm has been treated (surgically or with a catheter) in the last 24 hours with no complications.
- A CT scan before treatment showed significant bleeding (Fisher score higher than 1).
- Your kidneys work well (no severe kidney disease).
- You do not have severe infections or known allergies to dornase alfa or related products.
- You were independent before the hemorrhage (no significant disability).
- You are not pregnant, breastfeeding, or participating in another drug/device trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether nadroparine (a blood-thinning medicine) can improve outcomes after a type of brain bleed called subarachnoid hemorrhage. It focuses on people who have had a brain aneurysm treated with a procedure soon after the bleed.
This study tests whether starting aspirin early after a ruptured brain aneurysm (a weak bulge in a blood vessel) is safely repaired can help prevent complications. Aspirin may reduce the risk of stroke-like complications that sometimes follow this type of brain bleeding.
This trial tests whether placing a small drain in the lower back and giving a clot-dissolving medicine (urokinase) into the fluid around the brain can help people recover from a severe bleeding stroke caused by a brain aneurysm. It is for patients who are treated quickly after the bleed.
This trial studies deferoxamine, a medicine that targets iron-related injury, in people with an aneurysmal subarachnoid hemorrhage (a brain bleed caused by a burst aneurysm). It aims to improve neurologic recovery after the aneurysm is treated.
This trial studies a spinal fluid (CSF) treatment to help prevent dangerous blood-vessel tightening (vasospasm) after a type of brain bleed caused by an aneurysm. If you qualify, the goal is to reduce complications soon after aneurysm repair.
This study tests a natural compound called beta-sitosterol (from Gastrodia elata) to see if it can help people recover better after a brain aneurysm bleed. You must have had your aneurysm treated within 48 hours and be in relatively stable condition.
Hear when a new SAH (Subarachnoid Hemorrhage) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.